Gene delivery of bone morphogenetic protein-2 plasmid DNA promotes bone formation in a large animal model
- 6 August 2012
- journal article
- research article
- Published by Hindawi Limited in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 8 (10) , 763-770
Abstract
In the field of bone regeneration, BMP-2 is considered one of the most important growth factors because of its strong osteogenic activity, and is therefore extensively used in clinical practice. However, the short half-life of BMP-2 protein necessitates the use of supraphysiological doses, leading to severe side-effects. This study investigated the efficiency of bone formation at ectopic and orthotopic sites as a result of a low-cost, prolonged presence of BMP-2 in a large animal model. Constructs consisting of alginate hydrogel and BMP-2 cDNA, together acting as a non-viral gene-activated matrix, were combined with goat multipotent stromal cells (gMSCs) and implanted in spinal cassettes or, together with ceramic granules, intramuscularly in goats, both for 16 weeks. Bone formation occurred in all cell-seeded ectopic constructs, but the constructs containing both gMSCs and BMP-2 plasmid DNA showed higher collagen I and bone levels, indicating an osteogenic effect of the BMP-2 plasmid DNA. This was not seen in unseeded constructs, even though transfected, BMP-2-producing cells were detected in all constructs containing plasmid DNA. Orthotopic constructs showed mainly bone formation in the unseeded groups. Besides bone, calcified alginate was present in these groups, acting as a surface for new bone formation. In conclusion, transfection of seeded or resident cells from this DNA delivery system led to stable expression of BMP-2 during 16 weeks, and promoted osteogenic differentiation and subsequent bone formation in cell-seeded constructs at an ectopic location and in cell-free constructs at an orthotopic location in a large animal model. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
This publication has 31 references indexed in Scilit:
- Structural Regime Identification in Ionotropic Alginate Gels: Influence of the Cation Nature and Alginate StructureBiomacromolecules, 2011
- Distinct Tissue Formation by Heterogeneous Printing of Osteo- and Endothelial Progenitor CellsTissue Engineering Part A, 2011
- A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learnedThe Spine Journal, 2011
- Orthotopic Location Has Limited Benefit from Allogeneic or Autologous Multipotent Stromal Cells Seeded on Ceramic ScaffoldsTissue Engineering Part A, 2009
- Magnetic resonance imaging tracking of alginate beads used for drug delivery of growth factors at sites of cardiac damageMagnetic Resonance Imaging, 2009
- The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repairJournal of Cellular Physiology, 2008
- ALLOGENEIC MESENCHYMAL STEM CELLS REGENERATE BONE IN A CRITICAL-SIZED CANINE SEGMENTAL DEFECTJournal of Bone and Joint Surgery, 2003
- Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivoExperimental Hematology, 2002
- Unusual donor site reactions to calcium alginate dressingsBurns, 2000
- Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regenerationNature Medicine, 1999